Cordis, a global leader in interventional cardiovascular technology, today announced the groundbreaking results from the ...
The DCB is meant to address long-term stent-related complications and avoid adding yet another metal layer in ISR.
A stent can be life-saving during a heart attack, but it's not always necessary for those with coronary artery disease.
Cordis today announced new findings from a duo of studies supporting the use of its Selution SLR drug-eluting balloon (DEB) ...
Interv Cardiol. 2013;5(1):93-100. In-stent thrombosis More often seen when ≥1 stent used, long stented segments of coronary artery, drug-eluting stents, bifurcation lesion stenting Incomplete ...
The REC-CAGEFREE I trial1 by Chao Gao and colleagues describes the results of a multicentre trial in which a paclitaxel drug-coated balloon (DCB) did not reach expected non-inferiority compared with a ...
A new drug-eluting balloon can perform just as well as the standard treatment for patients with coronary in-stent restenosis (ISR) undergoing repeated ...
Editor’s note: This post is part of a Health Affairs Blog series titled “ORBITA: Lessons From A Landmark Trial," which focuses on the recent study finding that coronary stenting did not improve ...
The FDA approved a new emergency stent device to treat perforations in the blood vessels of the heart, the agency’s first new treatment option in the indication in 17 years. Deep tears in coronary ...
New research could change standard-of-care guidelines to improve outcomes for heart attack patients after coronary stenting procedures. Withdrawing aspirin one month after percutaneous coronary ...
Cardiologists are speaking out against a Lown Institute report that alleged 1 in 5 stents placed in Medicare recipients were considered “overuse,” Medscape reported Dec. 20. The October report looked ...
There has been a tremendous growth in percutaneous coronary interventions (PCIs) with stent implantation, even in cases where coronary artery bypass grafting (CABG) demonstrates superior long-term ...